Syngene International Limited (NSE:SYNGENE)
448.00
+6.00 (1.36%)
Jun 1, 2026, 3:30 PM IST
Syngene International Market Cap
Syngene International has a market cap or net worth of 178.35 billion as of June 1, 2026. Its market cap has decreased by -27.05% in one year.
Market Cap
178.35B
Enterprise Value
170.04B
Revenue
37.39B
Ranking
n/a
PE Ratio
56.93
Stock Price
448.00
Market Cap Chart
Since August 11, 2015, Syngene International's market cap has increased from 62.11B to 178.35B, an increase of 187.15%. That is a compound annual growth rate of 10.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 175.96B | -32.10% |
| Dec 31, 2025 | 259.16B | -24.09% |
| Dec 31, 2024 | 341.40B | 22.54% |
| Dec 29, 2023 | 278.60B | 19.79% |
| Dec 30, 2022 | 232.57B | -5.39% |
| Dec 31, 2021 | 245.81B | -3.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.32T |
| Divi's Laboratories | 1.77T |
| Apollo Hospitals Enterprise | 1.18T |
| Cipla | 1.13T |
| Pfizer | 210.37B |
| OneSource Specialty Pharma | 209.18B |
| Eris Lifesciences | 193.86B |
| Sagility | 192.12B |